Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide with Gemcitabine and Cisplatin in Metastatic Urothelial Carcinoma
NCT01342172Phase 2Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in urothelial carcinoma (UC), sponsored by Icahn School of Medicine at Mount Sinai. Started Mar 2011; status: terminated.
02
Drugs
lenalidomide
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01342172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342172.